Bank Julius Baer & Co
XBI icon

Bank Julius Baer & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bank Julius Baer & Co’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.38M Buy
27,694
+17,340
+167% +$2.34M 0.01% 268
2026
Q1 		$1.32M Sell
10,354
-2,352
-19% -$294K ﹤0.01% 360
2025
Q4 		$1.55M Buy
12,706
+2,023
+19% +$232K ﹤0.01% 344
2025
Q3 		$1.07M Sell
10,683
-1,500
-12% -$135K ﹤0.01% 365
2025
Q2 		$1.01M Sell
12,183
-3,500
-22% -$279K ﹤0.01% 336
2025
Q1 		$1.27M Buy
15,683
+2,529
+19% +$226K ﹤0.01% 304
2024
Q4 		$1.31M Buy
13,154
+487
+4% +$47.2K ﹤0.01% 298
2024
Q3 		$1.48M Sell
12,667
-826
-6% -$81.2K 0.01% 268
2024
Q2 		$1.39M Sell
13,493
-38,908
-74% -$3.49M 0.01% 220
2024
Q1 		$4.97M Sell
52,401
-560,889
-91% -$52M 0.02% 199
2023
Q4 		$54.8M Sell
613,290
-14,627
-2% -$1.09M 0.23% 92
2023
Q3 		$45.9M Buy
627,917
+26,728
+4% +$2.13M 0.27% 81
2023
Q2 		$50M Buy
601,189
+6,523
+1% +$546K 0.3% 76
2023
Q1 		$45.3M Sell
594,666
-34,434
-5% -$2.86M 0.29% 83
2022
Q4 		$52.3M Sell
629,100
-11,010
-2% -$891K 0.36% 69
2022
Q3 		$50.8M Sell
640,110
-64,877
-9% -$5.47M 0.39% 65
2022
Q2 		$52.4M Sell
704,987
-62,477
-8% -$4.69M 0.37% 65
2022
Q1 		$69M Buy
767,464
+38,654
+5% +$3.57M 0.41% 55
2021
Q4 		$81.6M Buy
728,810
+165,265
+29% +$19.9M 0.44% 54
2021
Q3 		$70.8M Buy
563,545
+127,688
+29% +$16.4M 0.44% 56
2021
Q2 		$59M Buy
435,857
+74,190
+21% +$9.75M 0.37% 60
2021
Q1 		$49.1M Buy
361,667
+60,396
+20% +$9.04M 0.37% 63
2020
Q4 		$42.4M Buy
301,271
+54,911
+22% +$7.03M 0.35% 60
2020
Q3 		$27.5M Sell
246,360
-36,224
-13% -$4.06M 0.27% 76
2020
Q2 		$31.4M Sell
282,584
-35,610
-11% -$3.51M 0.36% 62
2020
Q1 		$21.2M Buy
+318,194
New +$28.2M 0.49% 58

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Bank Julius Baer & Co's XBI Position: Q2 2026 in Review

Bank Julius Baer & Co increased its State Street SPDR S&P Biotech ETF (XBI) stake by 167% in Q2 2026, buying an estimated $2.34M and bringing the position to 27,694 shares worth $4.38M. The position accounts for 0.01% of the portfolio, ranked #268.

Bank Julius Baer & Co first reported a position in XBI in Q1 2020 and has held it in 26 quarters since. The position peaked at $81.6M in Q4 2021. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Bank Julius Baer & Co held 27,694 shares of State Street SPDR S&P Biotech ETF worth $4.38M as of Q2 2026.
  • Bank Julius Baer & Co bought 17,340 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $2.34M.
  • State Street SPDR S&P Biotech ETF made up 0.01% of Bank Julius Baer & Co's portfolio in Q2 2026, its #268 holding.
  • Bank Julius Baer & Co first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 26 quarters since.
  • Bank Julius Baer & Co's State Street SPDR S&P Biotech ETF position peaked at $81.6M in Q4 2021.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Bank Julius Baer & Co's 13F filing for Q2 2026, filed 10 Aug 2026.